The Experts – REVIVE

About
The Experts
Webinars
- External webinars
Resources
Forums
Talk to an expert
JOIN US
My account
- Logout

Loading...

The Experts

Our team of experts (more coming soon)

You are here:Home-The Experts

Jesús Rodríguez-Baño — Jesús Rodríguez-Baño
Professor of Medicine
University of Seville

Michael Barbachyn — Michael Barbachyn
Professor, Brummel Chair in Organic Chemistry
Calvin College

Greg Basarab — Greg Basarab
Principal Research Officer and Associate Director
University of Cape Town

Helen W Boucher — Helen W Boucher
Professor of Medicine, Director, Infectious Disease Fellowship Program
Tufts Medical Center

Pamela Brown — Pamela Brown
Consultant
Antibacterial Drug Discovery and Medicinal Chemistry

Karen Bush — Karen Bush
Professor of Practice
Department of Biology, Indiana University

Ryan Cirz — Ryan Cirz
Vice president, Infectious Disease Research and Head, Postdoctoral Program
Achaogen

Matthew Cooper — Matthew Cooper
Chief Executive Officer
Inflazome

Patrice Courvalin — Patrice Courvalin
Emeritus Professor
Department of Microbiology, Institut Pasteur

Mike Dawson — Mike Dawson
Director
Mike Dawson Antimicrobial Research Consultancy

George L Drusano — George L Drusano
Director
Institute for Therapeutic Innovation, University of Florida

Jacques Dumas — Jacques Dumas
Chief Scientific Officer
Tetraphase Pharmaceuticals

1
2
3
4
Next »

Share

Facebook Twitter Linkedin Reddit Email

REVIVE Hub

REVIVE is a space for everybody with an interest in antimicrobial R&D.

Launched in 2016 by the WHO and DNDi, the Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access. GARDP is currently operating within DNDi, which provides its governance.

Popular forum topics

Setting Up A 'Support' Service in Anti-Infectives
Immunomodulators
Medical need and priorities
Vitamin C in treatment of bacterial sepsis

Latest forum posts

Time above MIC for AUC/MIC drug?
PK/PD models to consolidate inconsistency between in vivo and in vitro data
What is the role of MIC for defining drug dosage?
Plant extracts for pan-drug resistant bugs?

CONNECT

Facebook
Twitter
Instagram
LinkedIn
YouTube
RSS
Events

GARDP
DNDi

© All Rights Reserved

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

This website uses cookies to ensure you get the best experience on our website. Read our cookie policyGOT IT!